Company news
Faron Pharmaceuticals Oy news in 2022
Faron Pharmaceuticals Oy's news releases, calls and decks from 2022, newest first.
Faron's Financial Calendar for 2023
December 23, 2022
BEXMAB Study Update
December 5, 2022
Faron Appoints Maija Hollmén PhD as CSO
December 1, 2022
Amendment Terms and Conditions with IPF Partners
November 18, 2022
Faron Announces Poster Presentation at SITC
November 2, 2022
Faron Announces Melanoma Cohort Data from MATINS
October 18, 2022
Proposed Issue and Placing of Shares
October 13, 2022
Top-Line Data on Bexmarilimab Dose Variation
September 20, 2022
Faron to Host Bexmarilimab Update Webcast
September 14, 2022
Traumakine Data Presented at MHSR Symposium
September 13, 2022
Faron to Present at Upcoming Conferences
September 7, 2022
Faron Reports 2022 Half-Year Financial Results
August 25, 2022
Registration of New Shares
June 28, 2022
Faron notice of EGM
June 16, 2022
Faron Announces Top-Line 12-Month Survival Results
June 15, 2022
First Patient Dosed in Ph I/II BEXMAB Combo Study
June 8, 2022
Presentation of Biomarker Analysis at ASCO
May 30, 2022
FDA and FIMEA approve BEXMAB study to begin
May 16, 2022
Ex Vivo Data Presented at EHA2022 Congress
May 12, 2022
Mol Cancer Ther Publishes Bexmarilimab Research
May 9, 2022
Faron Presents Melanoma Data at EADO
April 21, 2022
Managers' Transactions
April 8, 2022
Faron Closes HIBISCUS Trial
April 5, 2022
Faron´s Annual Report 2021 Published
March 25, 2022
Faron Publishes Research From INTEREST Trial
March 14, 2022
Presentation of Biomarker Data at AACR 2022
March 9, 2022
Notice of 2021 Full-Year Results and Annual Report
March 7, 2022
Faron presents at upcoming conferences
March 4, 2022
Faron Board Issues Warrants to IPF Partners
February 28, 2022
Faron Updates on Bexmarilimab Development Program
February 23, 2022
Faron Announces R&D Day
February 14, 2022
Scientific Reports Publishes INFORAAA Results
February 3, 2022
Holdings in Company
January 31, 2022
Faron at Proactive One2One Investor Forum
January 24, 2022
Faron to Present at Redeye Fight Cancer Seminar
January 17, 2022
Faron to Present at H.C. Wainwright BioConnect
January 5, 2022
Faron Appoints Marie-Louise Fjällskog as CMO
January 4, 2022
Decks in 2022
- Investor Presentation (October 2022)
Investor deck · 11 slides · Oct 13, 2022